Metastatic Biliary Tract Cancer
Showing 1 - 25 of >10,000
Locally Advanced Biliary Tract Cancer, Metastatic Biliary Tract Cancer Trial in Guangzhou (Camrelizumab and Apatinib Plus GP)
Not yet recruiting
- Locally Advanced Biliary Tract Cancer
- Metastatic Biliary Tract Cancer
- Camrelizumab and Apatinib Plus GP
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Feb 15, 2023
Biliary Tract Cancer Trial in Seoul (Pemetrexed 500 MG, Erlotinib)
Recruiting
- Biliary Tract Cancer
- Pemetrexed 500 MG
- Erlotinib
-
Seoul, Korea, Republic of
- +1 more
Jun 13, 2022
Metastatic Pancreatic Cancer, Metastatic Biliary Tract Cancer Trial in Herlev (Nivolumab, Ipilimumab, Radiotherapy)
Active, not recruiting
- Metastatic Pancreatic Cancer
- Metastatic Biliary Tract Cancer
- Nivolumab
- +2 more
-
Herlev, DenmarkHerlev & Gentofte Hospital
Mar 29, 2022
Advanced or Metastatic Biliary Tract Cancer Trial in China (MRG003)
Recruiting
- Advanced or Metastatic Biliary Tract Cancer
-
Beijing, Beijing, China
- +6 more
Dec 8, 2021
Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Germany, Spain, United Kingdom (Pembrolizumab, Cisplatin,
Active, not recruiting
- Biliary Tract Cancer
- +3 more
- Pembrolizumab
- +2 more
-
Leipzig, Germany
- +6 more
Jul 1, 2022
Advanced or Metastatic Biliary Tract Cancer Trial in China (MRG002)
Recruiting
- Advanced or Metastatic Biliary Tract Cancer
-
Bengbu, Anhui, China
- +6 more
Dec 8, 2021
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer Trial in Seoul
Not yet recruiting
- HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Feb 19, 2023
Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)
Not yet recruiting
- Biliary Tract Cancer
- +3 more
- (no location specified)
Aug 16, 2022
Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))
Recruiting
- Biliary Tract Cancer
- +2 more
- Tumor Infiltrating Lymphocytes (TIL)
-
Pittsburgh, PennsylvaniaAllyson Welsch
Jul 21, 2022
Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)
Not yet recruiting
- Pancreatic Neoplasms
- +2 more
- BI 907828
- (no location specified)
Aug 22, 2022
Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer Trial in Worldwide (RO7119929, Tocilizumab)
Completed
- Carcinoma, Hepatocellular
- +3 more
-
Duarte, California
- +9 more
Jan 27, 2023
Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,
Recruiting
- Hepatocellular Cancer
- +2 more
- durvalumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Biliary Tract Cancer Trial in United States (telotristat ethyl)
Terminated
- Biliary Tract Cancer
- telotristat ethyl
-
Gilbert, Arizona
- +13 more
Jan 14, 2022
Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,
Suspended
- Distal Bile Duct Adenocarcinoma
- +7 more
- Cisplatin
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Biliary Tract Cancer Trial in Worldwide (Varlitinib, Capecitabine, Placebo (for Varlitinib))
Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,
Recruiting
- Solid Tumor
- +7 more
- BNT141
- +2 more
-
Duarte, California
- +10 more
Aug 23, 2022
Biliary Tract Cancer Trial in Busan (5-Fluorouracil, Leucovorin, Irinotecan)
Completed
- Biliary Tract Cancer
- 5-Fluorouracil
- +4 more
-
Busan, Korea, Republic ofDong-A University Hospital
Feb 2, 2021